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Abstract 1 
Abamectin is one of the most widely used avermectins for agricultural pests control, but the 2 
emergence of resistance around the world is proving a major threat to its sustained application. 3 
Abamectin acts by directly activating glutamate-gated chloride channels (GluCls) and 4 
modulating other Cys-loop ion channels. To date, three mutations occurring in the 5 
transmembrane domain of arthropod GluCls are associated with target-site resistance to 6 
abamectin: A309V in Plutella xylostella GluCl (PxGluCl), G323D in Tetranychus urticae 7 
GluCl1 (TuGluCl1) and G326E in TuGluCl3. To compare the effects of these mutations in a 8 
single system, A309V/I/G and G315E (corresponding to G323 in TuGluCl1 and G326 in 9 
TuGluCl3) substitutions were introduced individually into the PxGluCl channel. Functional 10 
analysis using Xenopus oocytes showed that the A309V and G315E mutations reduced the 11 
sensitivity to abamectin by 4.8- and 493-fold, respectively. In contrast, the substitutions 12 
A309I/G show no significant effects on the response to abamectin. Interestingly, the A309I 13 
substitution increased the channel sensitivity to glutamate by one order of magnitude 14 
(~12-fold). Analysis of PxGluCl homology models indicates that the G315E mutation 15 
interferes with abamectin binding through a steric hindrance mechanism. In contrast, the 16 
structural consequences of the A309 mutations are not so clear and an allosteric modification 17 
of the binding site is the most likely mechanism. Overall the results show that both A309V 18 
and G315E mutations may contribute to target-site resistance to abamectin and may be 19 
important for the future prediction and monitoring of abamectin resistance in P. xylostella and 20 
other arthropod pests. 21 
 22 
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1. Introduction  1 
 Avermectins are naturally occurring 16-membered macrocyclic lactones produced by 2 
fermentation of the soil-dwelling microorganism Streptomyces avermitilis. These compounds 3 
have potent activity against many kinds of endoparasitic nematodes and ectoparasitic 4 
arthropods (Campbell, 2012). Since their first isolation in the 1970s, they have been applied 5 
globally for crop protection and animal health purposes. Within this family, abamectin 6 
(avermectin B1) is one of the most widely used compounds for agricultural pest management 7 
(Clark et al., 1995) and ivermectin (a synthetic derivative of avermectin B1, IVE) is active at 8 
extremely low dosage against a range of nematode and arthropod parasites (Campbell et al., 9 
1983). Avermectins are classified as neurotoxins, which act by directly activating or 10 
potentiating glutamate-gated chloride channels (GluCls) (and to a lesser extent γ-amino 11 
butyric acid (GABA)-gated chloride channels). GluCls contribute extensively to invertebrate 12 
nervous system function, including modulating locomotion, regulating feeding and mediating 13 
sensory inputs (Wolstenholme, 2012). As a result, modification of channel function by 14 
avermectins action can result in paralysis and death (Bloomquist, 1996, 2003).  15 
 GluCls belong to the Cys-loop superfamily of ligand-gated ion channels that assemble as 16 
pentamers to form a central ion-conducting pore; these GluCl receptors are present only in 17 
invertebrates (Jones and Sattelle, 2008; Wolstenholme, 2012). GluCls were first described in 18 
electrophysiological studies on locust muscle, when a biphasic change in its membrane 19 
potential was recorded and glutamate-enhanced chloride permeability resulted in the 20 
hyperpolarizing phase (Cull-Candy, 1976). The first cloned genes encoding GluCl subunits 21 
were glucl-α and glucl-β (now referred to glc-1 and glc-2, respectively) from the nematode 22 
Caenorhabditis elegans. When expressed in Xenopus oocytes, GluCls composed of glucl-α 23 
subunits responded to IVE but not to L-glutamate whereas homomeric glucl-β channels were 24 
unresponsive to IVE but were activated by L-glutamate (Cully et al., 1994; Daeffler et al., 25 
2014). The co-expression of both α and β subunits produced channels that responded to both 26 
glutamate and IVE independently and so more closed resembled the naturally-occurring 27 
receptor (Cully et al., 1994; Vassilatis et al., 1997; Slimko et al., 2002; Degani-Katzav et al., 28 
2016). The C. elegans GluCl gene family has since been expanded to six members (Jones and 29 
 4 
Sattelle, 2008). Genomic analysis has shown that a single GluCl gene, with variant transcripts 1 
produced by mRNA splicing and extensive editing, is present in several insects, including 2 
Drosophila melanogaster, Apis mellifera, Nasonia vitripennis, and Tribolium castaneum 3 
(Semenov and Pak, 1999; Jones and Sattelle, 2006, 2007; Jones et al., 2010; Knipple and 4 
Soderlund, 2010). Multiple GluCl genes have been identified in other organisms: two in 5 
Aplysia californica, six in Tetranychusur ticae and one in Lepeophtheirus salmonis (Tribble et 6 
al., 2007; Kehoe et al., 2009; Dermauw et al., 2012).  7 
 Several experiments based on functional analysis of IVE-resistant GluCl channels in 8 
nematodes predicted that IVE acts by insertion between transmembrane domain of GluCls 9 
(Dent et al., 2000; Njue et al., 2004). Recently, our knowledge of the structural and functional 10 
properties of the GluCls has been greatly advanced by the determination of the 11 
three-dimensional crystallographic structure of C. elegans GluClα channel (CeGluClα), which 12 
presented the first high-resolution view of a eukaryotic Cys-loop receptor (Hibbs and Gouaux, 13 
2011). This X-ray structure revealed that GluCls are arranged with five-fold symmetry and the 14 
transmembrane M2 helices form the pore lumen. The pore-lining residues of the M2 helices 15 
therefore determine the ion selectivity and conductance properties of the channel (Hibbs and 16 
Gouaux, 2011). This structure was co-crystallized with IVE, which binds in the 17 
transmembrane domain at subunit interfaces, lying between M3 and M1 helices of two 18 
adjacent subunits and making binding contacts with M2 and the M2-M3 loop. The 19 
endogenous ligand glutamate binds in the extracellular domain of the receptor in the classical 20 
neurotransmitter position, which is also located at the interface of adjacent subunits.  21 
 The diamondback moth, Plutella xylostella, is one of the few insect species that has 22 
evolved field resistance to all primary classes of insecticides (Furlong et al., 2013). As such it 23 
represents a valuable agricultural pest model to study the genetics and mechanisms of 24 
resistance development (Furlong et al., 2013). Gene mutation-mediated resistance 25 
mechanisms have been widely studied in P. xylostella. For example, mutations have been 26 
identified in occurring in genes encoding acetylcholinesterase, sodium channel, nicotinic 27 
acetylcholine receptor, GluCl, ryanodine receptor and ABC transporter C2. In addition, such 28 
mutations have been implicated in resistance to organophosphate, pyrethroid, spinosad, 29 
 5 
abamectin, chlorantraniliprle, Bt Cry1Ac toxin, indoxacarb and metaflumizone insecticides, 1 
respectively (Schuler et al., 1998; Lee et al., 2007; Baxter et al., 2010, 2011; Troczka et al., 2 
2012; Guo et al., 2014; Wang et al., 2016a, 2016b, 2016c). Abamectin has been used for P. 3 
xylostella control since the 1980s and at least 72 cases from four countries have been reported 4 
of field resistance to this chemical (APRD, 2017). A detailed study of the molecular 5 
mechanisms of abamectin resistance is important for designing strategies aimed at 6 
circumventing resistence it. In our previous work we identified a point mutation (A309V) in 7 
the transmembrane domain of P. xylostella glutamate-gated chloride channel receptor, 8 
PxGluCl, which has been evaluated to contribute ~10-fold increase to abamectin resistance in 9 
the resistant Roth-Abm strain (Wang et al., 2016b). We believe that characterizing the 10 
pharmacological properties of this mutation that evolved in PxGluCl could help in exploring 11 
the resistance mechanisms in this and other species and might have relevance in the 12 
development of new macrocyclic lactones insecticides. 13 
 In addition to A309V, only three other mutations in GluCls have been reported in 14 
association with resistance to avermectins (IVE & abamectin) in other arthropods (Fig. 1). 15 
The P299S mutation of the D. melanogaster DmGluCl channel is associated with a 3-fold 16 
resistance to IVE in this insect (Kane et al., 2000). The TuGluCl1 G323D and TuGluCl3 17 
G326E mutations are associated with 18- and 2000-fold resistance to abamectin in T. urticae, 18 
respectively (Kown et al., 2010; Dermauw et al., 2012). Of these, only the P299S mutation 19 
has been characterized electrophysiologically and a 14-fold reduction in IVE sensitivity was 20 
found when this substitution was introduced into DmGluCl (Kane et al., 2000). In the current 21 
study, we expressed A309V or G315E (equivalent to G323 in TuGluCl-1 and G326 in 22 
TuGluCl-3) mutants of PxGluCl in Xenopus laevis oocytes and compared their functional 23 
properties with wild-type receptors. In addition, further mutations of A309 to glycine or 24 
isoleucine were generated to investigate how substitutions at this position on the M3 helix 25 
could affect the functional effects of glutamate or abamectin. Homology models were 26 
generated to provide structural insight into the molecular mechanisms that underlie the 27 
abamectin resistance of these mutations.  28 
2. Materials and methods 29 
 6 
2.1. Chemicals and reagents 1 
 L-Glutamic acid ( ≧ 99%) and abamectin (B1a = 91.5%), used for two-electrode 2 
voltage-clamp recording, were purchased from Sigma-Aldrich (St. Louis, MO, USA) and 3 
Veyong bio-chemical (Shijiazhuang, Hebei, China), respectively. All the restricted enzymes 4 
used in this study, including EcoRI, XbaI, SmaI, NotI and the klenow fragment were 5 
purchased from Thermo Fisher Scientific (Waltham, MA, USA). 6 
2.2. Site-directed mutagenesis and cRNA synthesis 7 
 Total RNA of 4
th
-instar larvae from P. xylostella susceptible Roth strain was extracted by 8 
using the SV Total RNA Isolation System Kit (Promega, Madison, WI, USA) according to the 9 
manufacturer’s protocol. First-strand cDNA was synthesized from 1 μg total RNA using an 10 
oligo(dT)15 primer and M-MLV reverse transcriptase (Promega, Madison, WI, USA). The 11 
full-length cDNA of wild-type PxGluCl (GenBank accession no. JX014231.1) was amplified 12 
by PrimeSTAR HS DNA polymerase (TaKaRa, Japan) and PCR (35 cycles of 98 °C for 10 s, 13 
53 °C for 15s, and 72 °C for 90 s) with the forward primer PxGluCl_EcoRⅠ_F and the 14 
corresponding reverse primer PxGluCl_XbaⅠ_R (Table 1). Site-directed mutagenesis was 15 
performed by fusion PCR with wild-type PxGluCl cDNA as the template. All the cDNA 16 
constructs were ligated into the pEASY-Blunt Cloning vector (Beijing TransGen Biotech Co. 17 
Ltd, Beijing, China) and the isolated plasmid DNAs were examined by nucleotide sequencing 18 
(Life Technology, Shanghai, China). Five full-length P. xylostella GluCl cDNA (wild-type, 19 
A309V, A309I, A309G and G315E) were subcloned into the pGH19 vector, a modified 20 
version of plasmid pGEMHE, which contains 5´- and 3´-untranslated X. laevis beta-globin 21 
gene regions, and the presence of the mutations/substitutes were reconfirmed by sequencing. 22 
Plasmids were linearized with NotI, and capped RNAs were carried out using the T7 23 
mMessage mMachine Kit (Ambion, Life Technologies, Paisley, UK) according to the 24 
manufacturer’s instruction. Synthesized cRNAs were recovered by precipitation with 25 
isopropanol, dissolved in nuclease-free water at a final concentration of 500 ng/μL and stored 26 
at -80 °C until use. 27 
 7 
2.3. Functional expressions of PxGluCl variants in X. laevis oocytes 1 
 Mature healthy X. laevis oocytes (stage V–VI) were treated with collagenase (type IA; 2 2 
mg/ml; Sigma, USA) in calcium-free Barth’s solution (88 mM NaCl, 2.4 mM NaHCO3,15 3 
mM Tris-HCl, 1 mM KCl and 0.82 mM MgCl2) for about 25 min at room temperature, rinsed 4 
three times, and manually defolliculated before injection with cRNA. Oocytes were injected 5 
with 5-15 ng cRNA in a volume of 32.2 nL into the cytoplasm by using a Drummond variable 6 
volume microinjector. After injection, calcium-containing Barth’s solution (0.77 mM) with 7 
antibiotics (100 units/mL penicillin, 100 μg/mL streptomycin, 4 μg/mL kanamycin and 50 8 
μg/mL tetracycline) was used for oocytes’ incubation at 18 °C. Experiments were carried out 9 
at room temperature between 3 and 5 days after injection. 10 
2.4. Two-electrode voltage clamp electrophysiology 11 
 Two-electrode voltage clamp was used for recording whole-cell currents from the 12 
injected Xenopus oocytes. The oocytes were held in a recording bath and continuously 13 
perfused with a Ringer’s solution (115 mM NaCl, 2.5 mM KCl, 1.8 mM CaCl2 and 10 mM 14 
Hepes, pH 7.3). The glass capillary electrodes were filled with 3M KCl and have a resistance 15 
of 0.5-1.5 MΩ. Glutamate and abamectin induced inward currents were recorded with an 16 
OC-725C oocyte clamp (Warner Instruments, Hamden, CT, USA) at a holding potential of -60 17 
mV. Data acquisition and analysis were carried out using iWorx 408 data acquisition system 18 
and LabScribe software (iWorx Systems, Inc. Dover, NH, USA). Glutamate was dissolved in 19 
Ringer’s solution and applied to the oocytes for 3 s. After the glutamate perfusion, the oocytes 20 
were washed by Ringer’s solution for 2 min to assess their reproducibility. Abamectin was 21 
first dissolved in DMSO (0.1 mM) and then diluted with Ringer’s solution. The abamectin 22 
solution containing ≤ 0.1% DMSO was applied to oocytes for 15 s, and the oocytes were then 23 
washed for 3.5 min. Because of the effects of abamectin was irreversible, activated currents 24 
were normalized to the saturating glutamate-induced current in the same oocyte. 25 
Dose-response data were analyzed by nonlinear regression analysis using GraphPad Prism 5.0 26 
(GraphPad Software Inc., San Diego, CA, USA). Data were obtained for at least four oocytes 27 
from at least two frogs, and the values are given as means ± SEM. Statistical analysis was 28 
determined by a two-tail Student’s t-test. 29 
 8 
2.5. Homology modeling of PxGluCl mutants 1 
 A homology model of the open-state P. xylostella glutamate-gated chloride channel 2 
(GenBank accession no. JX014231.1) was generated as described (Wang et al., 2016b). A 3 
docking prediction of avermectin B1a with the open-state P. xylostella open-state model was 4 
also previously generated (Wang et al., 2016b). In this study, mutations were introduced into 5 
the channel model using Swiss-PdbViewer software (Guex et al., 1999) followed by 30 steps 6 
of steepest descent then 50 steps of conjugate gradient energy minimization. Figures were 7 
produced using PyMOL (DeLano Scientific, San Carlos, CA, USA). 8 
2.6. Genomic DNA extraction and mutations screening of PxGluCl in field populations 9 
 To determine whether the A309V and G315E mutations of PxGluCl have evolved in field 10 
population of P. xylostella, PCR amplification was carried out with genomic DNA isolated 11 
from individual larvae using the AxyPrep™Multisource Genomic DNA Miniprep Kit 12 
(Axygen Biosciences, Union, CA, USA) according to the manufacturer's protocol. A genomic 13 
DNA fragment of PxGluCl, covering the M3 region, was amplified as described previously 14 
(Wang et al., 2016b). 20-40 samples from seventeen P. xylostella populations collected in 15 
China during 2013-2015 were successful examined by direct nucleotide sequencing using a 16 
gene-specific primer (Wang et al., 2016b). The genotypes of 309 and 315 positions of the 17 
PxGluCl were identified according to sequence chromatograms. 18 
3. Results 19 
3.1. Response of wild-type and mutant channels to glutamate 20 
 We cloned the full-length cDNA sequence of wild-type PxGluCl (the most common 21 
isoform 3c9a) from the susceptible Roth strain. The natural-occurring mutations 22 
PxGluCl-A309V (found in P. xylostella by Wang et al., 2016b) and PxGluCl-G315E 23 
(equivalent to G326E mutation found in T. urticae by Dermauw et al., 2012) were then 24 
introduced and two other mutants (PxGluCl-A309I, PxGluCl-A309G) were generated by 25 
site-directed mutagenesis (Table 1 and Fig. 1). After expression in Xenopus oocytes, 26 
application of glutamate to these five channels induced inward currents in a dose-dependent 27 
fashion (Fig. 2). The dose-response curves gave EC50s of 19.93 ± 3.26 μM, 13.24 ± 1.05μM, 28 
 9 
1.67 ± 0.20μM，34.60 ± 2.83μM and 10.35 ± 3.67μM for wild-type, A309V, A309I, A309G 1 
and G315E channels, respectively, and Hill coefficients of 1.75 ± 0.18, 0.98 ± 0.06, 2.47 ± 2 
0.31,0.70 ± 0.05 and 1.03 ± 0.09 for wild-type, A309V, A309I, A309G and G315E channels, 3 
respectively (Table 2). The A309V and G315E increased the potency of glutamate by 1.5- and 4 
1.9-fold, respectively, without significant differences observed in EC50s when compared with 5 
the wild-type channel. 6 
 Interestingly, the A309I mutant exhibited an approximately 12-fold increase in glutamate 7 
sensitivity (Fig. 2B), and the difference of EC50s and Hill coefficients between A309I and 8 
wild-type channel were significant (p < 0.05). In contrast, the A309G mutant was less 9 
sensitive to glutamate, with a 1.7-fold reduction compared with wild-type. The Hill 10 
coefficient for the A309I and A309G mutants was 2.5 and 0.7, respectively, which suggests 11 
that the number of occupiable glutamate-binding sites in these receptors changed compared to 12 
wild-type. 13 
3.2. Response of wild-type and mutant channels to abamectin 14 
 Unlike the glutamate response, application of abamectin induced slow-to-activate and 15 
irreversible currents (Fig. 3A), and it was observed in all channels in a dose-dependent 16 
manner (Fig. 3B). The current did return to original baseline even after washing for several 17 
minutes with Ringer’s solution. The EC50s of abamectin calculated from the dose-response 18 
relationships of wild-type, A309V, A309I, A309G and G315E channels were 0.16 ± 0.05μM, 19 
0.78 ± 0.02 μM, 0.25 ± 0.01μM, 0.15 ± 0.02 μM and 80.32 ± 23.67 μM, respectively (Table 20 
2). The results showed that the curve for abamectin was right-shifted in A309V (Fig. 3B), and 21 
the EC50 reduced 5.0-fold but significantly (p = 0.0284), when compared with that of the 22 
wild-type. However, both of the A309I and A309G mutated channels had similar EC50 values 23 
(p > 0.05) to that wild-type channel (Table 2 and Fig. 3B). 24 
 In contrast, the G315E channel showed greatly reduced sensitivity to abamectin, yielding 25 
a 493-fold right-shift of EC50 compared with that of wild-type (Table 2 and Fig. 3B), and the 26 
observed reduction of EC50 between G315E and wild-type channel were significantly different 27 
(p = 0.0173). Especially, the response of G315E channel to the highest concentration of 28 
 10 
abamectin used in this study (0.3 mM), reached only 63 ± 4.1% of the response to saturating 1 
glutamate-activated current (0.1 mM). It is therefore predicted that the G315E mutation in 2 
PxGluCl may abolish abamectin potency. 3 
3.3. Molecular models of PxGluCl mutants 4 
 A model of PxGluCl in the open state and in complex with abamectin was previously 5 
generated (Wang et al., 2016b) using the crystal structure of CeGluClα in complex with IVE 6 
(Hibbs and Gouaux, 2011) as the homology template. As found previously with the A309V 7 
mutation, there were no steric clashes encountered when A309 was substituted with either 8 
glycine or isoleucine (Fig. 4). Furthermore, even introduction of the larger isoleucine 9 
side-chain did not result in novel binding contacts forming with abamectin. This is due to the 10 
register of the M3 helix whereby the 309 side chain is orientated away from the insecticide 11 
binding site (Fig. 4).  12 
    G315 is also located on M3 but, in contrast to A309, the side chain of this residue is 13 
orientated towards the ligand binding domain (Fig. 5). This glycine is predicted to form van 14 
der Waals interactions with abamectin, which is also found with IVE and the conserved M3 15 
glycine in the open-state CeGluClα structure (Hibbs and Gouaux, 2011). The effect of the 16 
G315E mutation was to produce a major steric clash with the benzofuran moiety of abamectin 17 
(Fig. 5).  18 
3.4. Mutation screening in field populations 19 
 As has been described in Wang et al. (2016b), we have established a rapid detection 20 
method for the mutation occurred in M3 by using the direct-sequencing chromatograph. The 21 
A309V mutation was first identified in Roth-Abm, which was obtained from a field 22 
population TH with high-level of abamectin resistance (Pu et al., 2010), indicating that 23 
A309V was present in the field. Both TH13 and TH16 were also collected in 2013 and 2016 24 
from Tonghai County, Yunnan Province, China. Genotype detection has revealed that the 25 
TH16 population consisted of 16 homozygous wild-type (Ala at position 309) and 4 26 
heterozygous (Ala/Val) individuals, and the mutant frequency reached to 10% (Table 3). The 27 
TH13 population collected 2yrs ago had also been detected carrying 6.25% mutant alleles. By 28 
 11 
contrast, the A309V mutation was not detected in five populations from Southeast China 1 
which had evolved high levels of resistance to abamectin (49- to 253-fold, unpublished data). 2 
However, 2 of 8 populations (KS14 and KS15) from Eastern China have been shown to carry 3 
3.33% and 1.67% mutant alleles, respectively, although both of them had low levels of 4 
resistance to abamectin. In general, heterozygous and homozygous mutant-type individuals 5 
with the A309V mutation have been detected in field populations collected from China, but 6 
the reported mutations (G323D and G326E in TuGluCls) equivalent to G315 position of 7 
PxGluCl have not been screened in the 17 field populations. 8 
4. Discussion 9 
 In this study we cloned and functionally expressed PxGluCl from an 10 
abamectin-susceptible strain of P. xylostella. The functional effects of mutations relevant to 11 
abamectin resistance were also characterized. In addition, populations of abamectin-resistant 12 
P. xylostella were genotyped to detect the occurrence of mutations at the A309 or G315 13 
positions in the field. We previously demonstrated that the A309V mutation of PxGluCl was 14 
strongly associated with a 10-fold increase in abamectin resistance in P. xylostella Roth-Abm 15 
strain (Wang et al., 2016b). Here we show by expressing the wild-type or A309V channels in 16 
oocytes that the mutant exhibits a modest but significant (~5-fold) reduction of abamectin 17 
sensitivity relative to the wild-type channel. This finding strongly suggests that target-site 18 
resistance plays a role in abamectin resistance of P. xylostella pest populations in the field. 19 
 We hypothesized that A309V may confer resistance by allosterically modifying the 20 
abamectin binding site (Wang et al., 2016b). To investigate this further, A309G and A309I 21 
mutants were generated, corresponding to residues with side chains that are either smaller or 22 
bigger than wild-type or A309V. The A309G mutation showed equivalent abamectin 23 
sensitivity compared with wild-type whereas the A309I channel showed a 1.5-fold decrease in 24 
abamectin sensitivity, which contrasts with the 5-fold resistance exhibited by A309V. 25 
Modelling of the receptor shows, as with A309V (Wang et al., 2016b), the A309G and even 26 
the larger A309I side chain can be accommodated without sterically perturbing the structure 27 
(Fig. 4). In addition, substitutions at the 309 position are still too far from the abamectin 28 
binding site to interact directly with the ligand, further supporting the hypothesis of an 29 
 12 
allosteric mechanism underlying resistance.  1 
 Intriguingly, A309 substitutions also affected glutamate sensitivity. A 1.7-fold reduction 2 
of glutamate sensitivity was detected with A309G, a 1.5-fold increase in sensitivity with 3 
A309V and surprisingly the A309I had increased glutamate sensitivity by one order of 4 
magnitude (12-fold). The 309 position is located on the top of the M3 helix and so distal from 5 
the glutamate binding site (see Fig. 6A in Wang et al., 2016b). Nevertheless, it is contiguous 6 
with the M2-M3 linker, which is critical for transmitting neurotransmitter-induced 7 
conformational changes in the extracellular domain to the transmembrane domain to gate the 8 
pore (Althoff et al., 2014). Degani-Katzav et al. (2016) identified a mutation in the 9 
IVE-binding site of M1 (αL279W; equivalent to α(-)L218 of CeGluCl crystal structure) that 10 
reduced the EC50 of glutamate by about 25-fold, when compared with the C. elegans wild 11 
type receptor. Similarly, Daeffler et al. (2014) introduced several mutant amino acids of 12 
varying size and polarity in to the M2 helix of C. elegans GluClβ receptor, four of these 13 
mutations led to 9- to 44-fold increase in channel sensitivity to glutamate, respectively. In the 14 
current study, it appears that larger residues at the top of M3 of PxGluCl facilitate channel 15 
opening, although the model reveals that the replacement of the alanine side chain with the 16 
larger isoleucine side chain didn't produce any steric clashes. Further studies will be required 17 
to determine why the A309I mutant is more sensitive to glutamate and to explain why the Hill 18 
coefficient has increased from 1.8 to 2.5, which suggests the presence of an additional 19 
glutamate binding site. Yet the effect of the A309I mutation clearly demonstrates the 20 
influence of this 309 position on GluCl pharmacology.  21 
 In the case of the A309V receptor, it is possible that this mutation does not allosterically 22 
modify the binding site for abamectin, thus inhibiting its binding. Instead this mutation may 23 
allosterically counteract the functional effect of the insecticide upon binding. We attempted to 24 
investigate this by quantifying binding affinity using radioligand binding studies of 25 
[
3
H]-avermectin to membranes of the PxGluCls expressed in Drosophila S2 cell lines. 26 
Unfortunately these studies were not successful, due to extremely high levels of nonspecific 27 
binding of [
3
H]-avermectin to membranes (data not shown). This is almost certainly due to the 28 
very lipophilic nature of the radioligand. Similar problems have been reported in binding 29 
 13 
studies with pyrethroids on insect sodium channels (Rossignol, 1988; Pauron et al., 1989; 1 
Dong and Scott, 1994).  2 
 The current work also represents the first effort to characterize the pharmacological effect 3 
of naturally occurring G315E mutation. This mutation is tightly linked to abamectin 4 
resistance in the MAR-AB strain of T. urticae, with a resistance level of more than 2000-fold 5 
(Dermauw et al., 2012). The equivalent G323D mutation is associated with a 18-fold 6 
resistance to abamectin in an isogenic-resistant strain (Kwon et al., 2010). Our 7 
electrophysiology findings show that introducing the G315E mutation into PxGluCl results in 8 
493-fold resistance to abamectin. Glycine is entirely conserved in M3 helix of GluCls and the 9 
role of substitutions at this “M3-Gly” position in conferring resistance to avermectin 10 
compounds has been well characterized (Lynagh and Lynch, 2012). Human glycine receptor 11 
α1 receptor (GlyRα1) has an alanine at the equivalent position and showed that 12 
IVE-sensitivity (50-fold) can be conferred on an IVE-insensitive receptor by introducing a 13 
M3-Gly at this position. Furthermore, the reciprocal introduction in the Haemonchus 14 
contortus α3BGluCl, G329A (the human GlyRα1 equivalent position) shifts the EC50 of IVE 15 
activation from 39 nM up to 1200 μM. This indicates that M3-Gly is essential for high IVE 16 
sensitivity in both glycine- and glutamate- gated Cys-loop receptors (Lynagh and Lynch, 17 
2010). The proposed resistance mechanism for M3-Gly mutations (Lynagh and Lynch, 2012) 18 
is that a larger side chain at this position sterically obstructs entry of an avermectin ligand to 19 
the narrow gap between the M3 helix of principal subunit and M1 of the complementary 20 
subunit and thus limits access to the insecticide binding site.  21 
 Recently, resistance to abamectin began to emerge and develop in field populations of 22 
various arthropod pests in worldwide, including twenty-one species form Lepidoperan, Acari, 23 
Blattodea, Coleoptera, Diptera, Hemiptera, Mesostigmata and Thysanoptera (APRD, 2017). 24 
Without doubt, identification of abamectin-resistant mutations will be very valuable for 25 
elucidating the molecular mechanisms and monitoring the development of resistance to 26 
abamectin. In this work, in total 503 larvae sampled from 17 field P. xylostella populations 27 
were analyzed for the estimation of the frequency of the A309V and G315D/E mutations, 28 
previously associated with abamectin resistance in arthropods. The A309V mutation was 29 
 14 
detected in four populations with lower frequencies. Two populations collected from Tonghai 1 
county in 2013 and 2016 (TH13, TH16), where abamectin was mainly employed in the 2 
control of P. xylostella and control failure always reported by local farmers, showed 6.25% 3 
and 10% mutant allele frequencies. In contrast, G315D/E has not been detected in any tested 4 
populations from China. Resistance development of field populations is complex, and 5 
resistant phenotype might be associated with metabolic detoxification of abamectin and other 6 
potential mechanisms. Although insecticide resistance development may or may not result in 7 
control failure, it has given rise to the loss of many selective compounds that could otherwise 8 
have formed part of insecticide resistance management (IRM) and, more broadly, integrated 9 
pest management programs for P. xylostella. In view of the A309V mutation detected in P. 10 
xylostella field populations, and the G314D and G326E mutations have been reported in T. 11 
urticae, originating from rose greenhouses with varied frequencies (from 5% to 100%) (Ilias 12 
et al., 2016), molecular diagnostic assays for early identification and monitoring of 13 
low-frequency A309V and G315D/E alleles of PxGluCl in a globally collected samples is 14 
required in IRM strategies of P. xylostella. 15 
 In conclusion, here we functionally characterized the potency of abamectin and the 16 
endogenous neurotransmitter glutamate on the activity of wild-type and mutant PxGluCls. 17 
Two naturally occurring mutations in the M3 helix of arthropod GluCls that are associated 18 
with abamectin resistance reduced the channel sensitivity to this compound. We suggest that 19 
two different mechanisms are involved in abamectin target-site resistance, with the G315 20 
mutation directly sterically hindering abamectin binding while the A309V mutation modifies 21 
the allosteric binding site. Fitness analysis is required to define the physiological function 22 
and/or negative effects of these mutations on insects. Our study provides direct evidences that 23 
A309V and G315E mutations on M3 helix can result in abamectin resistance. We also suggest 24 
that resistant alleles should be monitored continuously, which will provide useful information 25 
for investigating the evolution and spread of well-characterized resistance genes. 26 
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Table 1 1 
Sequences of primers used in this study. 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
Primer Use Sequence (5' to 3') 
PxGluCl_EcoRI_F Full-length cDNA amplification and fusion PCR CGGAATTCGGTTTGCTGAGTTGGAGAATGGACG 
PxGluCl_XbaI_R Full-length cDNA amplification and fusion PCR GCTCTAGATGCCAGTGGAACGATGCTGATGC 
Px_A309V_F Amplify the downstream fragment of A to V mutation GTATCATACACAAAGGTCATAGACGTATGGACTGG 
Px_A309V_R Amplify the upstream fragment of A to V mutation CCAGTCCATACGTCTATGACCTTTGTGTATGATAC 
Px_A309I_F Amplify the downstream fragment of A to I mutation GTATCATACACAAAGATCATAGACGTATGGACTGG 
Px_A309I_R Amplify the upstream fragment of A to I mutation CCAGTCCATACGTCTATGATCTTTGTGTATGATAC 
Px_A309G_F Amplify the downstream fragment of A to G mutation GTATCATACACAAAGGGCATAGACGTATGGACTGG 
Px_A309G_R Amplify the upstream fragment of A to G mutation CCAGTCCATACGTCTATGCCCTTTGTGTATGATAC 
Px_G315E_F Amplify the downstream fragment of G to E mutation TAGACGTATGGACTGAGGTTTGTTTAACATTCG 
Px_G315E_R Amplify the upstream fragment of G to E mutation CGAATGTTAAACAAACCTCAGTCCATACGTCTA 
 20 
Table 2 1 
EC50 values and Hill coefficients of L-glutamate- and abamectin-induced responses of 2 
PxGluCls expressed in Xenopus laevis oocytes. Data were obtained by nonlinear regression 3 
analyses and indicated as means and 95% confidence limits (n = 5 ~ 6). 4 
 5 
Variants 
L-glutamate (μM)   Abamectin (μM) 
n EC50 95% CL nH 95%CL 
 
n EC50 95% CL nH 95%CL 
wild-type 6 19.93 17.43-22.79 1.8 1.4-2.1 
 
5 0.163 0.118-0.226 1.4 0.8-1.9 
A309V 6 13.24 11.73-14.94 1.0 0.9-1.1 
 
5 0.780 0.648-0.940 1.0 0.8-1.2 
A309I 6 1.673 1.514-1.847 2.5 2.0-2.9 
 
5 0.250 0.155-0.404 1.1 0.6-1.6 
A309G 6 34.60 27.47-43.60 0.7 0.6-0.8 
 
5 0.153 0.132-0.177 1.8 1.4-2.2 
G315E 6 10.35 8.689-12.33 1.0 0.9-1.2   5 80.320 53.87-119.7 0.5 0.4-0.6 
 21 
Table 3 1 
Levels of resistance to abamectin and the A309V mutation frequencies in field P. xylostella 2 
populations from China. 3 
 4 
Populations RF 
a
 N
 b
 
A309V Mutation  
Ala/Ala Ala/Val Val/Val frequency (%)  
Pops. from Southwest China 
    
 
TH13 345 40 35 5 0 6.25  
MD13 491 36 36 0 0 0  
SH13 383 36 36 0 0 0  
TH16 92 20 16 4 0 10  
Pops. from Southeast China 
    
 
GZ14 49 30 30 0 0 0   
ZC14 151 30 30 0 0 0   
SZ14 253 30 30 0 0 0   
HZ14 162 30 30 0 0 0   
HK15 86 22 22 0 0 0   
Pops. from Eastern China 
   
 
NJ14 4.7 30 30 0 0 0   
HF14 12 30 30 0 0 0   
JN14 24 30 30 0 0 0   
KS14 3.1 30 29 0 1 3.33   
NJ15 14 30 30 0 0 0   
HF15 3.3 30 30 0 0 0   
JN15 2 30 30 0 0 0   
KS15 12 30 29 1 0 1.67   
a 
RF (resistance factor) = LC50 (resistant strain) ÷ LC50 (Roth). Unpublished data. 
b
 Number of insects genotyped. A, alanine (Ala); V, valine (Val). 
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Fig. 1. Alignment of the amino acid sequences in transmembrane domain 2 and 3 of glutamate-gated chloride channel genes of C. elegans 3 
(CeGluCl, GenBank accession code AAA50785.1 ), D. melanogaster (DmGluCl, GenBank accession codeU58776.1), T. urticae (TuGluCl1, 4 
TuGluCl3, GenBank accession code XM_015938823.1 and NP_001310061.1) and P. xylostella (PxGluCl-WT, PxGluCl-A309V, PxGluCl-A309I, 5 
PxGluCl-A309G, PxGluCl-G315E). Fully conserved resides are shaded in black, while lower similar positions are shaded in grey. The P229S, 6 
G314D and G326E mutations in DmGluCl, TuGluCl1 and TuGluCl3, associated with ivermectin/abamectin resistance, are indicated in blue 7 
(Kane et al., 2000; Kwon et al., 2010; Dermauw et al., 2012). The A309V mutation in PxGluCl associated with abamectin resistance (Wang et al., 8 
2016b) and the introduced A309I/G and G315E substitutes in this study are indicated in red. 9 
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 1 
Fig. 2. Glutamate responses of wild- and mutant-type homomeric PxGluCls expressed in 2 
Xenopus oocytes. (A) Traces of electrical responses induced by L-glutamate from the 3 
wild-type ion channels. (B) Normalized dose-response curves for glutamate induced currents 4 
for oocytes expressing wild-type, A309V, A309I, A309G and G315E mutant channels. The 5 
data are means ± SEM (n = 6). 6 
 24 
 1 
Fig. 3. Abamectin responses of wild- and mutant-type homomeric PxGluCls expressed in 2 
Xenopus oocytes. (A) Examples of electrical responses induced by saturated glutamate (100 3 
μM) and abamectin (1μM) in the wild-type, A309V and G315E mutant ion channels, 4 
respectively. (B) Normalized dose-response curves for abamectin induced currents for oocytes 5 
expressing wild-type, A309V, A309I, A309G and G315E mutant channels. The data are means 6 
± SEM (n = 5). 7 
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 1 
Fig. 4. Models of wild-type PxGluCl and A309 mutations. Side view of the transmembrane 2 
domain with channel monomers shown as cartoon. The 309 position is shown in black 3 
spacefill and abamectin is shown as yellow sticks with a transparent surface. 4 
 26 
 1 
Fig. 5. Models of wild-type PxGluCl and the G315E mutation. Side view and extracellular 2 
view of the abamectin binding site with channel monomers shown as cartoon. The 315 3 
position is shown in black spacefill and abamectin is as yellow sticks with a transparent 4 
surface.  5 
